Seroprevalence of poliovirus antibodies before and after polio vaccine switch in 2012 and 2017 in Beijing

References

• World Health Organization. 10 facts about the eradication of poliomyelitis [EB/OL]. 2017 April 25. https://www.who.int/features/factfiles/polio/en/
   Google Scholar
• Global Wild Poliovirus 2014-2019. 2019. Accessed 9 November 2019 http://polioeradication.org/wp-content/uploads/2016/08/weekly-polio-global-update-03Aug19.pdf
   Google Scholar
• Moturi EK, Porter KA, Wassilak SG, Tangermann RH, Diop OM, Burns CC, Jafari H. EIS officer, CDC. Progress toward polio eradication - worldwide, 2013-2014. MMWR Morb Mortal Wkly Rep. 2014;63:468–72.
   PubMed Web of Science ®Google Scholar
• Luo HM, Yu WZ, Wen N, Wang HB, Dong CX, Fan CX, Li L. Application of poliomyelitis vaccine and recommendation on switch of immunization strategies in China. Chin J Vaccines Immunization. 2014;20:172–76.
   Google Scholar
• Zhang LF, Wen N, Cao LS, Su QR, Fan CQ, Yu WZ, Zheng JS, Li L, Wang HQ, HM L. Comparison of poliomyelitis vaccine routine immunization data from different sources in 8 provinces (municipalities) in China. Chin J Vaccines Immunization. 2015;21:400–04.
   Google Scholar
• Yu WZ, Wen N, Zhang Y, Wang HB, Fan CX, Zhu SL, Xu WB, Liang XF, Luo HM, Li L. Poliomyelitis eradication in china: 1953–2012. J Infect Dis. 2014;210(Suppl 1):S268–74. doi:10.1093/infdis/jit332.
   PubMedGoogle Scholar
• Wang HB, Zhu SL, Zheng JS. Sero-survey of polio antibodies during wild poliovirus outbreak in Southern Xinjiang Uygur Autonomous Region, China. PLoS One. 2014;9:e800691–8.
   Web of Science ®Google Scholar
• Luo HM, Zhang Y, Wang XQ, Yu WZ, Wen N, Yan DM, Wang HQ, Wushouer F, Wang HB, Xu AQ, et al. Identification and control of a poliomyelitis outbreak in Xinjiang, China. N Engl J Med. 2013;369(21):1981–90. doi:10.1056/NEJMoa1303368.
   PubMed Web of Science ®Google Scholar
• Zhao D, Ma R, Zhou T, Yang F, Wu J, Sun H, Liu F, Lu L, Li X, Zuo S, et al. Introduction of inactivated poliovirus vaccine and impact on vaccine-associated paralytic poliomyelitis-Beijing, China, 2014–2016. MMWR Morb Mortal Wkly Rep. 2017;66(49):1357–61. doi:10.15585/mmwr.mm6649a4.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Progress toward poliomyelitis eradication—Myanmar,1996–1999. MMWR Morb Mortal Wkly Rep. 1999;48(42):967–71.
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention (CDC). Importation of wild poliovirus into Qinghai Province—China, 1999. MMWR Morb Mortal Wkly Rep. 2000;49(6):113–14.
   PubMedGoogle Scholar
• Wen N, Luo HM, Wang HB, Cui FQ, Zheng H, Wang FZ, Zhang Y, Fan CX, Hao LX, Ma C, et al. Study on risk assessment and response of wild poliovirus importation after polio imported into Xinjiang Uygur Autonomous Region, 2011. Chin J Vaccines Immunization. 2013;19:193–98.
   Google Scholar
• Kew OM, Sutter RW, de Gourville EM, Dowdle WR, Pallansch MA. Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Annu Rev Microbiol. 2005;59:587–635. doi:10.1146/annurev.micro.58.030603.123625.
   PubMed Web of Science ®Google Scholar
• Jenkins HE, Aylward RB, Gasasira A, Donnelly CA, Mwanza M, Corander J, Garnier S, Chauvin C, Abanida E, Pate MA, et al. Implications of a circulating vaccine-derived poliovirus in Nigeria. N Engl J Med. 2010;362(25):2360–69. doi:10.1056/NEJMoa0910074.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Progress toward the global interruption of wild poliovirus type 2 transmission, 1999. MMWR Morb Mortal Wkly Rep. 1999;48(33):736–738, 747.
   PubMedGoogle Scholar
• Wang HB, Luo HM, Li L, Fan CX, Hao LX, Ma C, Su QR, Yang H, Reilly KH, Wang HQ, et al. Vaccine-derived poliovirus surveillance in China during 2001-2013: the potential challenge for maintaining polio free status. BMC Infect Dis. 2017;17(1):742–49. doi:10.1186/s12879-017-2849-z.
   PubMedGoogle Scholar
• Blake IM, Pons-Salort M, Molodecky NA, Diop OM, Chenoweth P, Bandyopadhyay AS, Zaffran M, Sutter RW, Grassly NC. Type 2 poliovirus detection after global withdrawal of trivalent oral vaccine. N Engl J Med. 2018;379(9):834–45. doi:10.1056/NEJMoa1716677.
   PubMed Web of Science ®Google Scholar
• Zipursky S, Vandelaer J, Polio Endgame: BA. Lessons learned from the immunization systems management group. J Infect Dis. 2017;216(suppl_1):S9–S14. doi:10.1093/infdis/jiw592.
   PubMedGoogle Scholar
• World Health Organization. Manual for the virological investigation of polio[EB/OL]. WHO/EPI/GEN 1997.
   Google Scholar
• Zarocostas J. Imports of polio to China and western Africa threaten global eradication. BMJ. 2011;343(343):d6186. doi:10.1136/bmj.d6186.
   PubMedGoogle Scholar
• Opare JKL, Odoom JK, Akweongo P, Afari EA1, Pappoe M. Poliovirus antibody levels and lameness among individuals in three regions of Ghana. Hum Vaccin Immun. 2019; 15(9):2050-2059.
   Google Scholar
• Wang HB, Yu WZ, Wang XQ, Wushouer F, Wang J-P, Wang D-Y, Cui F-Q, Zheng J-S, Wen N, Ji Y-X. An outbreak following importation of wild poliovirus in Xinjiang Uyghur Autonomous Region, China, 2011. BMC Infect Dis. 2015;15(1):34–42. doi:10.1186/s12879-015-0761-y.
   Google Scholar
• Patel MK, Konde MK, Didi-Ngossaki BH, Ndinga E, Yogolelo R, Salla M, Shaba K, Everts J, Armstrong GL, Daniels D, et al. An outbreak of wild poliovirus in the Republic of Congo, 2010-2011. Clin Infectious Dis. 2012;55(10):1291–98. doi:10.1093/cid/cis714.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Polio field census and vaccination of underserved populations - Northern Nigeria, 2012-2013. MMWR Morb Mortal Wkly Rep. 2013;62(33):663–65.
   PubMed Web of Science ®Google Scholar
• Patel M, Orenstein W. A world free of polio–the final steps. N Engl J Med. 2016;374(6):501–03. doi:10.1056/NEJMp1514467.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Hwang S, Lee S, Kwon Y, Park K, Park YJ, Bae GR, Lee SW, Jeong YS, Hyeon JY. A national cross-sectional study for poliovirus seroprevalence in the Republic of Korea in 2012: implication for deficiency in immunity to polio among middle-aged people. BMC Infect Dis. 2015;15(1):164. doi:10.1186/s12879-015-0894-z.
   PubMedGoogle Scholar
• World Health Organization. Polio vaccines: WHO position paper.[EB/OL]. 2016 https://www.who.int/immunization/documents/positionpapers/en/
   Google Scholar
• Lu L, Li X, Zhang H, Liu D, Zhang Z, Wang H, Liu F, Ning Z, Li J, Pang X. Immunogenicity and persistence from different 3-dose schedules of live and inactivated polio vaccines in Chinese infants. Vaccine. 2015;33(36):4653–58. doi:10.1016/j.vaccine.2014.08.091.
   PubMed Web of Science ®Google Scholar
• Hird TR, Grassly NC, Andino R. Systematic review of mucosal immunity induced by oral and inactivated poliovirus vaccines against virus shedding following oral poliovirus challenge. PLoS Pathog. 2012;8(4):e1002599. doi:10.1371/journal.ppat.1002599.
   PubMed Web of Science ®Google Scholar
• Simasathien S, Migasena S, Beuvery C, van Steenis G, Samakoses R, Pitisuttitham P, Vesikari T. Comparison of enhanced potency inactivated poliovirus vaccine (EIPV) Versus standard oral poliovirus vaccine (OPV) in Thai infants. Scand J Infect Dis. 1994;26(6):731–38. doi:10.3109/00365549409008643.
   PubMed Web of Science ®Google Scholar
• Circulating Vaccine-derived Poliovirus(cVDPV). [EB/OL]. 2019. http://polioeradication.org/polio-today/polio-now/this-week/circulating-vaccine-derived-poliovirus/.
   Google Scholar